Edaravone, an ROS Scavenger, Ameliorates Photoreceptor Cell Death After Experimental Retinal Detachment

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2011 Feb 12

PMID 21310909

Citations 33

Authors

Mi In Roh

Yusuke Murakami

Aristomenis Thanos

Demetrios G Vavvas

Joan W Miller

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate whether edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, would be neuroprotective against photoreceptor cell death in a rat model of retinal detachment (RD).

Methods: RD was induced in adult Brown Norway rats by subretinal injection of sodium hyaluronate. Edaravone (3, 5, or 10 mg/kg) or physiologic saline was administered intraperitoneally once a day until death on day 3 or 5. Oxidative stress in the retina was assessed by 4-hydroxynonenal staining or ELISA for protein carbonyl content. Photoreceptor death was assessed by TUNEL and measurement of the outer nuclear layer thickness. Western blot analysis and caspase activity assays were performed. Inflammatory cytokine secretion and inflammatory cell infiltration were evaluated by ELISA and immunostaining, respectively.

Results: RD resulted in increased generation of ROS. Treatment with 5 mg/kg edaravone significantly reduced the ROS level, along with a decrease in TUNEL-positive cells in the photoreceptor layer. A caspase assay also confirmed decreased activation of caspase-3, -8, and -9 in RD treated with edaravone. The level of the antiapoptotic Bcl-2 was increased in detached retinas after edaravone treatment, whereas the levels of the stress-activated p-ERK1/2 were decreased. In addition, edaravone treatment resulted in a significant decrease in the levels of TNF-α, MCP-1, and macrophage infiltration.

Conclusions: Oxidative stress plays an important role in photoreceptor cell death after RD. Edaravone treatment may aid in preventing photoreceptor cell death after RD by suppressing ROS-induced photoreceptor damage.

Citing Articles

Effects of Selected Antioxidants on Electroretinography in Rodent Diabetic Retinopathy.

Dutczak R, Pietrucha-Dutczak M Antioxidants (Basel). 2025; 14(1).

PMID: 39857355 PMC: 11762402. DOI: 10.3390/antiox14010021.

ER Stress and Mitochondrial Perturbations Regulate Cell Death in Retinal Detachment: Exploring the Role of HIF1α.

Kaur B, Scavuzzi B, Yang M, Yao J, Jia L, Abcouwer S Invest Ophthalmol Vis Sci. 2024; 65(11):39.

PMID: 39325470 PMC: 11437674. DOI: 10.1167/iovs.65.11.39.

Anti-inflammatory potential of simvastatin and amfenac in ARPE-19 cells; insights in preventing re-detachment and proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery.

Harju N, Hytti M, Kolari O, Nisula H, Loukovaara S, Kauppinen A Int Ophthalmol. 2024; 44(1):158.

PMID: 38530532 PMC: 10965607. DOI: 10.1007/s10792-024-03067-z.

Inflammation and Oxidative Stress Gene Variability in Retinal Detachment Patients with and without Proliferative Vitreoretinopathy.

Lumi X, Confalonieri F, Ravnik-Glavac M, Goricar K, Blagus T, Dolzan V Genes (Basel). 2023; 14(4).

PMID: 37107562 PMC: 10137369. DOI: 10.3390/genes14040804.

Expression levels of ROS and Atg proteins in the vitreous in rhegmatogenous retinal detachment.

Huang N, Gao X, Li J, Lu X, Zhu H, Dong K Int J Ophthalmol. 2023; 16(3):348-353.

PMID: 36935782 PMC: 10009606. DOI: 10.18240/ijo.2023.03.03.

References

Harper S, Wilkie N . MAPKs: new targets for neurodegeneration. Expert Opin Ther Targets. 2003; 7(2):187-200. DOI: 10.1517/14728222.7.2.187. View

Luo Y, DeFranco D . Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem. 2006; 281(24):16436-42. DOI: 10.1074/jbc.M512430200. View

Zacks D . Gene transcription profile of the detached retina (An AOS Thesis). Trans Am Ophthalmol Soc. 2010; 107:343-82. PMC: 2814587. View

Li J, Edward D, Lam T, Tso M . Amelioration of retinal photic injury by a combination of flunarizine and dimethylthiourea. Exp Eye Res. 1993; 56(1):71-8. DOI: 10.1006/exer.1993.1010. View

Kono H, Rusyn I, Uesugi T, Yamashina S, Connor H, Dikalova A . Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol. 2001; 280(5):G1005-12. DOI: 10.1152/ajpgi.2001.280.5.G1005. View

Zacks D, Boehlke C, Richards A, Zheng Q . Role of the Fas-signaling pathway in photoreceptor neuroprotection. Arch Ophthalmol. 2007; 125(10):1389-95. DOI: 10.1001/archopht.125.10.1389. View

Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y . Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci. 2004; 221(1-2):11-7. DOI: 10.1016/j.jns.2004.03.002. View

Kono H, Rusyn I, Bradford B, Connor H, Mason R, Thurman R . Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Ther. 2000; 293(1):296-303. View

Martinou J, Green D . Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2001; 2(1):63-7. DOI: 10.1038/35048069. View

10.

Chen J, Flannery J, LaVail M, STEINBERG R, Xu J, Simon M . bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci U S A. 1996; 93(14):7042-7. PMC: 38932. DOI: 10.1073/pnas.93.14.7042. View

11.

Kono H, Fujii H, Matsuda M, Yamamoto M, Matsumoto Y . Gadolinium chloride prevents mortality in hepatectomized rats given endotoxin. J Surg Res. 2001; 96(2):204-10. DOI: 10.1006/jsre.2001.6099. View

12.

Komeima K, Rogers B, Lu L, Campochiaro P . Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2006; 103(30):11300-5. PMC: 1544081. DOI: 10.1073/pnas.0604056103. View

13.

Bhatt L, Groeger G, McDermott K, Cotter T . Rod and cone photoreceptor cells produce ROS in response to stress in a live retinal explant system. Mol Vis. 2010; 16:283-93. PMC: 2825485. View

14.

Hetts S . To die or not to die: an overview of apoptosis and its role in disease. JAMA. 1998; 279(4):300-7. DOI: 10.1001/jama.279.4.300. View

15.

Wen J, Watanabe K, Ma M, Yamaguchi K, Tachikawa H, Kodama M . Edaravone inhibits JNK-c-Jun pathway and restores anti-oxidative defense after ischemia-reperfusion injury in aged rats. Biol Pharm Bull. 2006; 29(4):713-8. DOI: 10.1248/bpb.29.713. View

16.

Glotin A, Calipel A, Brossas J, Faussat A, Treton J, Mascarelli F . Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest Ophthalmol Vis Sci. 2006; 47(10):4614-23. DOI: 10.1167/iovs.06-0297. View

17.

Feher J, Lengyel G, Blazovics A . Oxidative stress in the liver and biliary tract diseases. Scand J Gastroenterol Suppl. 1998; 228:38-46. DOI: 10.1080/003655298750026543. View

18.

Hishida A . Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance. Clin Exp Nephrol. 2007; 11(4):292-296. DOI: 10.1007/s10157-007-0495-2. View

19.

Maeno T, Tano R, Takenaka H, Mano T . Edaravone (MCI-186) is effective as a free radical scavenger following arteriovenous sheathotomy for treatment of macular oedema associated with branch retinal vein occlusion. Br J Ophthalmol. 2009; 93(11):1479-82. PMC: 2760724. DOI: 10.1136/bjo.2008.154930. View

20.

Sun H, Nathans J . ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-trans-retinal-mediated photooxidative damage in vitro. Implications for retinal disease. J Biol Chem. 2001; 276(15):11766-74. DOI: 10.1074/jbc.M010152200. View